NASDAQ : DRIO
DarioHealth Corp. — Key statistics
Healthcare · Health Information Services · United States
Last price 3 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 29.40M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 29.40M |
| Enterprise Value | 47.85M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 9.80M |
| Shares Outstanding | 9.80M |
| Shares Change (YoY) | +171.67% |
| Shares Change (QoQ) | +41.95% |
| Owned by Insiders (%) | 23.14% |
| Owned by Institutions (%) | 3.67% |
| Float | 6.91M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.40 |
| Forward PS | 1.22 |
| PB Ratio | 0.40 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 2.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.31 |
| Quick Ratio | 1.86 |
| Debt / Equity | 0.59 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.01 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -59.91% |
| Return on Assets (ROA) | -19.42% |
| Return on Invested Capital (ROIC) | -21.73% |
| Return on Capital Employed (ROCE) | -36.58% |
| Weighted Average Cost of Capital (WACC) | 11.88% |
| Revenue Per Employee | $127,261 |
| Profits Per Employee | -$42,410 |
| Employee Count | 165 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 1.94 |
Taxes
| Measure | Value |
|---|
| Income Tax | 467,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.18 |
| 52-Week Price Change | -78.65% |
| 50-Day Moving Average | 5.98 |
| 200-Day Moving Average | 7.75 |
| Relative Strength Index (RSI) | 23.26 |
| Average Volume (20 Days) | 58,961 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 81,229 |
| Short Previous Month | 81,615 |
| Short % of Shares Out | 0.83% |
| Short % of Float | 1.18% |
| Short Ratio (days to cover) | 4.48 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 21.00M |
| Gross Profit | 12.93M |
| Operating Income | -31.83M |
| Pretax Income | -35.20M |
| Net Income | -7.00M |
| EBITDA | -29.71M |
| EBIT | -31.83M |
| Loss Per Share | -$0.95 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 13.96M |
| Total Debt | 32.41M |
| Net Cash | -18.45M |
| Net Cash Per Share | -$1.88 |
| Equity (Book Value) | 55.09M |
| Book Value Per Share | 7.50 |
| Working Capital | 12.55M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -25.35M |
| Capital Expenditures | -136,000 |
| Depreciation & Amortization | 2.12M |
| Net Borrowing | n/a |
| Free Cash Flow | -25.48M |
| FCF Per Share | -$2.60 |
Margins
| Measure | Value |
|---|
| Gross Margin | 61.57% |
| Operating Margin | -151.60% |
| Pretax Margin | -167.65% |
| Profit Margin | -169.87% |
| EBITDA Margin | -141.51% |
| EBIT Margin | -151.60% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -171.67% |
| Shareholder Yield | -171.67% |
| Earnings Yield | -31.57% |
| FCF Yield | -86.67% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $12.33 |
| Price Target Difference | 311.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 24.86% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Aug 28, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -6.64 |
| Piotroski F-Score | n/a |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |